Francine Dina Salinitri Pharm.D.

Francine Dina Salinitri Pharm.D.

Associate Professor (Clinical), Director of Experiential Education



Office location

EACPHS, Room 4126


Pharmacy Practice


Associate Professor (clinical), Department of Pharmacy Practice

Degrees and Certifications

  • Doctor of Pharmacy, Wayne State University, 2003
  • Bachelor of Health Sciences, Wayne State University, 2001
  • Bachelor of Science, University of Windsor, 2001
  • Bachelor of Education, University of Windsor, 2001
  • Pharmacy Nephrology Resident, Henry Ford Hospital, 2004

Positions and Employment

  • Associate Professor (Clinical), Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences, 2014-present
  • Clinical Pharmacy Nephrology Specialist, Oakwood Hospital and Medical Center (Dearborn, MI), 2004-present
  • Assistant Professor (Clinical), Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences, 2004-2014

Professional Memberships

  • American Association of College of Pharmacy
  • American College of Clinical Pharmacist Association
  • American Society of Health-System Pharmacists

Areas of Expertise

  • Treatment of patients with diabetes and chronic kidney disease
  • Problem-based learning
  • Objective structured clinical examinations

Recent Publications

Journal Articles

  1. Moser L*, Berlie H, Salinitri FD, McCuistion M, Slaughter RL. Enhancing Academic Success by Creating a Community of Learners. Am J Pharm Educ. 2015;79(5):Article 70.
  2. Salinitri FD, Wilhelm S, Crabtree BL*. Facilitating Facilitators: Enhancing PBL through a structured facilitator development program. International Journal of Problem Based Learning. 2015;9(1): 72-82. Available at:
  3. Pinelli NR*, Patel A, Salinitri FD. Co-Administration of liraglutide with tacrolimus in kidney transplant recipients: A case series. Diabetes Care. 2013;36(10):e171-172.
  4. Salinitri FD*, Pinelli NR, Martin ET, Jaber LA. Insulin sensitivity and secretion in Arab Americans with glucose intolerance. Diabetes Technology and Therapeutics. 2013;15(11): DOI: 10.1089/dia.2013.0045.
  5. Nemerovski CW*, Salinitri FD, Morbitzer K, Moser LR. Aspirin for the primary prevention of cardiovascular disease events. Pharmacotherapy. 2012;32(11):1020-1035.
  6. Salinitri FD*, O???Connell ME, Garwood CL, Tutag-Lehr V, Abdallah K. An objective structured clinical examination (OSCE) to assess problem-based learning. Am J Pharm Educ. 2012;76(3):Article 44.
  7. Salinitri FD, Hsaiky L, Pinelli NR*. Hepatitis C virus infection complicated by kidney disease. Nephro-Urol Mon. 2011;3(4):308-9.
  8. Salinitri FD*, Desai N, Berlie H. Pharmacotherapeutic blood pressure management in a chronic kidney disease patient. AACN Adv Crit Care. 2009;20(3):205-215

Book Chapters

  1. Salinitri FD*, Berlie H. Diabetes Management. In Hudson JQ, Mason DL eds. Nephrology Pharmacotherapy: A Pharmacist's Guide to Advanced Kidney Disease and Medication Management. Fresenius Medical Care, Inc; 2015. (in press)
  2. Wilpula E*, Salinitri FD. Module 2, Chapter 5: Foundations in Pharmacology and Clinical Applications in Nephrology Nursing. Pages 291-326. In American Nephrology Nurses Association, eds. The Core Curriculum for Nephrology Nursing, 6th edition. 2015.
  3. Berlie HD*, Salinitri FD. "Canagliflozin: A new agent and class for the treatment of type 2 diabetes" (update). In DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. 8th ed. New York: McGraw-Hill; 2013.

Research Connect link

Return to profile list

150 years in the heart of Detroit